vTv Therapeutics (VTVT) Stock Price
$20.2 0%
to add to portfolio
AI Score
-
Alternative
8 -
Fundamental
1 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on vTv Therapeutics, AI stock picks, stock alerts and much more.
VTVT AI Stock Analysis
AI stock analysis for VTVT is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like vTv Therapeutics (VTVT) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
vTv Therapeutics (VTVT) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of vTv Therapeutics (VTVT), currently trading at $20.2, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About VTVT
-
vTv Therapeutics Inc.
-
Symbol
VTVT
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
52.8M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
VTVT Alternative Data
Web Traffic
vTv Therapeutics receives an estimated 2327 monthly visitors to vtvtherapeutics.com.
-
Web Traffic
2327
-
Change from Previous Month
91.2%
-
3 Month Change
30%
-
YoY Change
30%
News Mentions
vTv Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
Reddit Mentions
vTv Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Facebook Engagement
vTv Therapeutics has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Job Postings
vTv Therapeutics currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Twitter Followers
vTv Therapeutics has 350 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.3% over the last month.
-
Twitter Followers
350
-
Daily Change
0.3%
-
1 Month Change
0.3%
-
3 Month Change
0.8%
-
YoY Change
0.8%
Business Outlook
-
Business Outlook
100
-
Change from Previous Month
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, vTv Therapeutics has 48 employees.
-
LinkedIn Employees
48
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
VTVT Financials
VTVT Key Metrics
-
Total Revenue
$0
-
Net Income
-$4.8M
-
Earnings per Share
-$0.88
-
Free cash flow
-$6.4M
-
EBITDA
-$5.8M
-
EBITDA Ratio
0
-
Total Assets
$43.2M
VTVT 2-year Revenue & Income
VTVT 2-year Free Cash Flow
VTVT Technicals
VTVT SMA
VTVT RSI
FAQ
What's the current price of vTv Therapeutics (VTVT) Stock?
The price of an vTv Therapeutics (VTVT) share is $20.2.
What's the market cap of vTv Therapeutics?
The current market cap of vTv Therapeutics is 52.8M.
Should I buy or sell VTVT?
vTv Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, vTv Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is vTv Therapeutics a good investment?
The current analysis of vTv Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in vTv Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy vTv Therapeutics (VTVT) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for vTv Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to vTv Therapeutics (VTVT) that investors often compare it to?
vTv Therapeutics (VTVT) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for vTv Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast vTv Therapeutics' stock price to be around $20.06 in 2026. Starting from the current price of $20.2, this represents a 0.7% change in price, indicating a neutral outlook for the stock.
How to buy vTv Therapeutics (VTVT) Stock?
vTv Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy vTv Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.